Novamind to Present at PsyTech Summit

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

TORONTO, ONTARIO / ACCESSWIRE / October 26, 2020 / Novamind Ventures Inc. (“Novamind“), a mental health and wellness company specialized in psychedelic-assisted psychotherapy, is pleased to announce that it will present at PsyTech’s upcoming virtual summit: “A Global Dialogue on the Future of Psychedelic Medicine”. The event is set to take place on October 27th, 2020 and is free of charge for attendees.

From 6:00-7:00 PM EST, Novamind will present two talks titled:

i) Global Access to Psychedelic Medicines and Innovative Research
Hosted by: Yaron Conforti – Chief Executive Officer, Novamind

ii) Psychedelic Medicine: A Pathway Towards Systemic Healing
Hosted by: Reid Robison, MD, MBA – Chief Medical Officer, Novamind and Adele Lafrance, PhD – Senior Consultant, Research Scientist, Novamind

The PsyTech Summit will be streamed from eight cities across the globe and will feature leaders in psychedelic research, therapy, technology, advocacy, and business. Other distinguished speakers include Rick Doblin, Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), Professor Matthew Johnson of Johns Hopkins University, author, psychiatrist and psychopharmacologist, Dr. Julie Holland, and Dr. Robin Carhart-Harris, Founder of the Centre for Psychedelic Research at Imperial College London.

For more information, or to register for the Psytech summit, visit www.psytech.biz.

About Novamind
Novamind is building a global network of clinics, retreats and research sites to serve the regulated psychedelics industry. We provide access to safe, legal psychedelic experiences, while advancing research for psychedelic medicine. For more information visit www.novamind.ca.

Contact Information
Novamind
Yaron Conforti, CEO and Director
T: +1 (647) 953 9512
E: contact@novamind.ca

SOURCE: Novamind

View source version on accesswire.com:
https://www.accesswire.com/612327/Novamind-to-Present-at-PsyTech-Summit

Staff

Recent Posts

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for…

2 hours ago

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

2 hours ago

Waystar to Present at J.P. Morgan Healthcare Conference

LEHI, Utah and LOUISVILLE, Ky., Jan. 6, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY),…

2 hours ago

MARPAI ANNOUNCES SECOND TRANCHE OF NON-DILUTIVE GROWTH FUNDING WITH UP TO $5 MILLION FROM JGB

TAMPA, Fla., Jan. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a…

2 hours ago

Mérieux NutriSciences Completes Acquisition of Bureau Veritas’ Food Testing Activities in Canada and the U.S.

CHICAGO, Jan. 6, 2025 /PRNewswire/ -- Mérieux NutriSciences, a world leader in food safety, quality, and…

2 hours ago

ImageTrend Acquires biospatial

LAKEVILLE, Minn., Jan. 6, 2025 /PRNewswire/ -- Today ImageTrend announces the purchase of biospatial, based…

2 hours ago